Romain Kessler

Romain Kessler

Auto-generated profile, based on publicly available information

Romain Kessler

Pneumology Department, Lung Transplant Program, NHC, Strasbourg University Hospital, Strasbourg, France

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2010 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
RKR. Kessler
R. Kessler
MPM.R. Partridge
M.R. Partridge
MMMarc Miravitlles
Marc Miravitlles
MCM. Cazzola
M. Cazzola
CVC. Vogelmeier
C. Vogelmeier
JOJ. Ostinelli
J. Ostinelli
In between exacerbations, chronic obstructive pulmonary disease (COPD) is usually regarded as a stable condition, but there is increasing recognition of variability in this state. This cross-sectional study assessed patients' perception of symptom variability.Participants were outpatients >45 yrs old with COPD, current or ex-smokers, forced expiratory volume in 1 s (FEV1) <50% predicted, FEV1/forced vital capacity <0.7 and no exacerbation leading to therapeutic intervention in the previous 3 months. Patients' perceptions of COPD symptoms and their impact on daily life activities were recorded. Alterations in therapy use in response to COPD worsening were also recorded.COPD symptoms were experienced by 2,258 (92.5%) out of 2,441 patients during the 7 days before interview. Breathlessness was the most common symptom (72.5%). Daily and/or weekly symptom variability was reported by 62.7% of symptomatic patients; the morning was the worst time of day. Factors associated with perception of variability of breathlessness included younger age, symptom severity and recruitment to the study by general practitioners. The perception of variability was significantly different between European countries or regions.Patient-perceived COPD symptoms vary over the day and the week, and impact on daily activities; morning being the worst time of day. The majority of patients appear not to adjust treatment when symptoms worsen.

1 August 2001 in Chest
Verified
Journal Article
Closed access
PDF file
RKRomain Kessler
Romain Kessler
ACAri Chaouat
Ari Chaouat
PSPhilippe Schinkewitch
Philippe Schinkewitch
MFMichèle Faller
Michèle Faller
SCSimone Casel
Simone Casel
EWEmmanuel Weitzenblum
Emmanuel Weitzenblum

8 June 2016 in Sleep Medicine
Verified
Journal Article
Open access
SRSirimon Reutrakul
Sirimon Reutrakul
ATAmmarin Thakkinstian
Ammarin Thakkinstian
TAThunyarat Anothaisintawee
Thunyarat Anothaisintawee
SCSasipas Chontong
Sasipas Chontong
ABAnne-Laure Borel
Anne-Laure Borel
KKKristen L Knutson
Kristen L Knutson
The association between inadequate sleep and type 2 diabetes has garnered much attention, but little is known about sleep and type 1 diabetes (T1D). Our objectives were to conduct a systematic review and meta-analysis comparing sleep in persons with and without T1D, and to explore relationships between sleep and glycemic control in T1D. Studies were identified from Medline and Scopus. Studies reporting measures of sleep in T1D patients and controls, and/or associations between sleep and glycemic control, were selected. A total of 22 studies were eligible for the meta-analysis. Children with T1D had shorter sleep duration (mean difference [MD] = -26.4 minutes; 95% confidence interval [CI] = -35.4, -17.7) than controls. Adults with T1D reported poorer sleep quality (MD in standardized sleep quality score = 0.51; 95% CI = 0.33, 0.70), with higher scores reflecting worse sleep quality) than controls, but there was no difference in self-reported sleep duration. Adults with TID who reported sleeping >6 hours had lower hemoglobin A1c (HbA1c) levels than those sleeping ≤6 hours (MD = -0.24%; 95% CI = -0.47, -0.02), and participants reporting good sleep quality had lower HbA1c than those with poor sleep quality (MD = -0.19%; 95% CI = -0.30, -0.08). The estimated prevalence of obstructive sleep apnea (OSA) in adults with TID was 51.9% (95% CI = 31.2, 72.6). Patients with moderate-to-severe OSA had a trend toward higher HbA1c (MD = 0.39%, 95% CI = -0.08, 0.87). T1D was associated with poorer sleep and high prevalence of OSA. Poor sleep quality, shorter sleep duration, and OSA were associated with suboptimal glycemic control in T1D patients.

1 July 2006 in Chest
Verified
Journal Article
Closed access
RKRomain Kessler
Romain Kessler
ESElisabeth Ståhl
Elisabeth Ståhl
CVClaus Vogelmeier
Claus Vogelmeier
JHJohn Haughney
John Haughney
ETElyse Trudeau
Elyse Trudeau
MPMartyn R. Partridge
Martyn R. Partridge

1 March 2002 in RadioGraphics
Verified
Journal Article
Closed access
MJMi-Young Jeung
Mi-Young Jeung
BGBernard Gasser
Bernard Gasser
AGAfshin Gangi
Afshin Gangi
DCDominique Charneau
Dominique Charneau
XDXavier Ducroq
Xavier Ducroq
CRCatherine Roy
Catherine Roy
Bronchial carcinoid tumors are neuroendocrine neoplasms that range from low-grade typical carcinoids to more aggressive atypical carcinoids and therefore demonstrate a wide spectrum of clinical behaviors and histologic features. Typical and atypical bronchial carcinoids have similar imaging features. Because most bronchial carcinoids are located in central airways, radiologic findings are usually related to bronchial obstruction. Central bronchial carcinoids manifest as an endobronchial nodule or hilar or perihilar mass with a close anatomic relationship to the bronchus. The mass is usually a well-defined, round or ovoid lesion and may be slightly lobulated at radiography and computed tomography (CT). Associated atelectasis, air trapping, obstructing pneumonitis, and mucoid impaction may also be seen. Peripheral bronchial carcinoids appear as solitary nodules. Calcification is common and is easily visualized at CT. Bronchial carcinoids demonstrate high signal intensity on T2-weighted and short-inversion-t...

12 August 2010 in European Neurology
Verified
Journal Article
Closed access
PDF file
QWQisi Wu
Qisi Wu
CMChristian Marescaux
Christian Marescaux
VWValérie Wolff
Valérie Wolff
MJMi-Young Jeung
Mi-Young Jeung
RKRomain Kessler
Romain Kessler
YCYangmei Chen
Yangmei Chen
Tacrolimus (TAC) is an immunosuppressant drug discovered in 1984 by Fujisawa Pharmaceutical Co., Ltd. This drug belongs to the group of calcineurin inhibitors, which has been proven highly effective in preventing acute rejection after transplantation of solid organs. However, neurotoxicity and nephrotoxicity are its major adverse effects. Posterior reversible encephalopathy syndrome (PRES) is the most severe and dramatic consequence of calcineurin inhibitor neurotoxicity. It was initially described by Hinchey et al. in 1996 [N Engl J Med 1996;334:494–450]. Patients typically present with altered mental status, headache, focal neurological deficits, visual disturbances, and seizures. Magnetic resonance imaging is the most sensitive imaging test to detect this. With the more deep-going studies done recently, we have learnt more about this entity. It was noted that this syndrome is frequently reversible, rarely limited to the posterior regions of the brain, and often located in gray matter and cortex as well as in white matter. Therefore, in this review, the focus is on the current understanding of clinical recognition, pathogenesis, neuroimaging and management of TAC-associated PRES after solid organ transplantation.